NCT05553704View on ClinicalTrials.gov

Metformin in Patients With Ulcerative Colitis Treated With Mesalamine

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Metformin

metformin group will take mesalamine 1 gm three times daily plus metformin 500 mg two times daily

Trial Locations (1)

35511

Faculty of Medicine, Mansoura University, Al Mansurah

All Listed Sponsors
collaborator

Mounir Hussein Bahgat Internal Medicine Department Mansoura University

UNKNOWN

collaborator

Maha Mohamed Maher Internal Medicine Department Mansoura University

UNKNOWN

lead

Tanta University

OTHER